Buy Zynerba Pharmaceuticals Stock | ZYNE Stock Price & Latest News | Public.com
ZYNE

Zynerba Pharmaceuticals

$0.00 (0.00%)Today
    Small Market Cap
    View Zynerba Pharmaceuticals (ZYNE) stock trends here

    About ZYNE

    Zynerba Pharmaceuticals, Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. It focuses on research and development of rare and near-rare neuropsychiatric conditions. The firm offers Zygel product, which formulated as a permeati...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.11
    -0.22
    -0.33
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.26

    Actual EPS
    Q2 2021

    Stats

    Market Cap$157,99M
    Volume104,77k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$9.00
    1 Year Low$3.12
    Open$3.79
    High$3.96
    Low$3.74

    Buy any stock with any amount of money.

    Download the App
    Download the app